New York Post
Bringing drug manufacture back to America (and New York): Another Trump triumph
July 28, 2020
New York and the Rochester-based Kodak Corp. are about to enjoy one of the greatest second acts in US industrial history. The US International Development Finance Corp., or DFC, a federal agency, is entering into a partnership that should position Kodak as one of the most strategically critical powerhouses in our domestic supply chain.
This is all possible because President Trump took decisive action authorizing the DFC to make loans under the Defense Production Act, the Korean War-era statute that allows the nation to mobilize manufacturing capability in times of crisis.
America is dangerously dependent on foreign supply chains for all three stages of drug production: starting materials used to manufacture active ingredients, the active ingredients themselves and the finished product in the form of tablets, pills and injectables.
Bringing drug manufacture back to America (and New York): Another Trump triumph
July 28, 2020
New York and the Rochester-based Kodak Corp. are about to enjoy one of the greatest second acts in US industrial history. The US International Development Finance Corp., or DFC, a federal agency, is entering into a partnership that should position Kodak as one of the most strategically critical powerhouses in our domestic supply chain.
This is all possible because President Trump took decisive action authorizing the DFC to make loans under the Defense Production Act, the Korean War-era statute that allows the nation to mobilize manufacturing capability in times of crisis.
America is dangerously dependent on foreign supply chains for all three stages of drug production: starting materials used to manufacture active ingredients, the active ingredients themselves and the finished product in the form of tablets, pills and injectables.
- 3
- Show all